- Home
- MNOV vs DOMH Comparison
MNOV vs DOMH Comparison
Compare MNOV & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- DOMH
- Stock Information
- Founded
- MNOV 2000
- DOMH 1967
- Country
- MNOV United States
- DOMH United States
- Employees
- MNOV N/A
- DOMH N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- MNOV Health Care
- DOMH Health Care
- Exchange
- MNOV Nasdaq
- DOMH Nasdaq
- Market Cap
- MNOV 68.2M
- DOMH 74.7M
- IPO Year
- MNOV 2005
- DOMH N/A
- Fundamental
- Price
- MNOV $1.23
- DOMH $5.22
- Analyst Decision
- MNOV Strong Buy
- DOMH
- Analyst Count
- MNOV 2
- DOMH 0
- Target Price
- MNOV $7.00
- DOMH N/A
- AVG Volume (30 Days)
- MNOV 20.6K
- DOMH 291.7K
- Earning Date
- MNOV 08-07-2025
- DOMH 08-07-2025
- Dividend Yield
- MNOV N/A
- DOMH 6.09%
- EPS Growth
- MNOV N/A
- DOMH N/A
- EPS
- MNOV N/A
- DOMH N/A
- Revenue
- MNOV N/A
- DOMH $24,891,000.00
- Revenue This Year
- MNOV N/A
- DOMH N/A
- Revenue Next Year
- MNOV N/A
- DOMH N/A
- P/E Ratio
- MNOV N/A
- DOMH N/A
- Revenue Growth
- MNOV N/A
- DOMH 630.80
- 52 Week Low
- MNOV $1.12
- DOMH $0.83
- 52 Week High
- MNOV $2.55
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- MNOV 40.69
- DOMH 50.19
- Support Level
- MNOV $1.32
- DOMH $4.72
- Resistance Level
- MNOV $1.38
- DOMH $5.50
- Average True Range (ATR)
- MNOV 0.04
- DOMH 0.36
- MACD
- MNOV 0.00
- DOMH -0.04
- Stochastic Oscillator
- MNOV 36.87
- DOMH 36.76
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.